In this issue:
– Disease burden of atopic dermatitis in patients in Australia and NZ
– Inflammasomes: Emerging therapeutic targets in HS?
– Effects of semaglutide in obese patients with HS
– Effects of spesolimab in patients with moderate to severe HS
– Safety of systemic vs topical corticosteroids in patients with bullous pemphigoid
– Remission dynamics and prognostic factors in lichen planopilaris
– Efficacy and safety of secukinumab in adults with lichen planus
– Time to relapse after withdrawal of different biologics in patients with psoriasis
– Adverse reactions to isotretinoin reported to CARM
– Association of inflammatory bowel disease with isotretinoin use
Expert contributor
Dr Louise Reiche is a NZ physician trained vocational specialist dermatologist. She has additional special interests in eczema, patch testing, high risk skin cancer surveillance, preventative dermatology health and clinical research. Louise is Co-Founder and Chairperson for the NZ Dermatology Research Trust.
Expert contributor
Dr Karen Koch is a South African specialist dermatologist. She completed her Masters in Medicine through the University of Witwatersrand. Karen worked in a hospital practice in Johannesburg before immigrating to New Zealand in 2019 to join the Waikato Hospital Dermatology Department. She is an executive member of the NZ Dermatological Society. She has a […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.